Literature DB >> 25344830

Automated liquid culture system misses isoniazid heteroresistance in Mycobacterium tuberculosis isolates with mutations in the promoter region of the inhA gene.

Z Zhang1, J Lu, Y Wang, Y Pang, Y Zhao.   

Abstract

Heteroresistance in Mycobacterium tuberculosis isolates remains the major challenge for phenotypic drug susceptibility testing (DST) methods to detect drug resistance. The aim of this study was to investigate the abilities of phenotypic DST methods to identify the isoniazid (INH) heteroresistance in M. tuberculosis. We found that the broth dilution method was able to detect INH resistance if 0.5 % resistant bacteria with mutations in the katG and oxyR-ahpC regions were present, while the detection limit ranged from 1 to 10 % for the INH-resistant strains harboring inhA mutations, which was associated with the different mutant types. Additionally, MGIT DST was able to find the recommended 1 % INH resistance due to katG mutations. In contrast, MGIT DST detected resistance in suspensions with 20 % resistant bacteria with inhA mutations. Statistical analysis revealed that the ability of the broth dilution method to detect heteroresistance was better than that of the MGIT DST (p = 0.004). When we further pairwise compared the two methods for detecting heteroresistance according to different mutant loci, the broth dilution method found more heteroresistance due to inhA mutations than MGIT DST (p = 0.001), while the differences for katG and oxyR-ahpC mutations were both not statistically significant (p > 0.05). In conclusion, our findings demonstrate that MGIT DST fails to detect INH heteroresistance in M. tuberculosis isolates with mutations in the promoter region of inhA. In addition, the broth dilution method is more sensitive than MGIT DST in finding INH heteroresistance, indicating that this method may serve as an alternative method to detect the heteroresistance of M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25344830     DOI: 10.1007/s10096-014-2262-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.

Authors:  Neel R Gandhi; Paul Nunn; Keertan Dheda; H Simon Schaaf; Matteo Zignol; Dick van Soolingen; Paul Jensen; Jaime Bayona
Journal:  Lancet       Date:  2010-05-22       Impact factor: 79.321

3.  Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.

Authors:  S G Franzblau; R S Witzig; J C McLaughlin; P Torres; G Madico; A Hernandez; M T Degnan; M B Cook; V K Quenzer; R M Ferguson; R H Gilman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.

Authors:  Hiroki Ando; Yuji Kondo; Toshinori Suetake; Emiko Toyota; Seiya Kato; Toru Mori; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

5.  National survey of drug-resistant tuberculosis in China.

Authors:  Yanlin Zhao; Shaofa Xu; Lixia Wang; Daniel P Chin; Shengfen Wang; Guanglu Jiang; Hui Xia; Yang Zhou; Qiang Li; Xichao Ou; Yu Pang; Yuanyuan Song; Bing Zhao; Hongtao Zhang; Guangxue He; Jing Guo; Yu Wang
Journal:  N Engl J Med       Date:  2012-06-07       Impact factor: 91.245

6.  Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.

Authors:  Juan-Carlos Palomino; Anandi Martin; Mirtha Camacho; Humberto Guerra; Jean Swings; Françoise Portaels
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

7.  Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan.

Authors:  S Hofmann-Thiel; J van Ingen; K Feldmann; L Turaev; G T Uzakova; G Murmusaeva; D van Soolingen; H Hoffmann
Journal:  Eur Respir J       Date:  2008-10-01       Impact factor: 16.671

8.  Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations.

Authors:  Leen Rigouts; Mourad Gumusboga; Willem Bram de Rijk; Elie Nduwamahoro; Cécile Uwizeye; Bouke de Jong; Armand Van Deun
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

9.  Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methods.

Authors:  Dorte Bek Folkvardsen; Vibeke Ø Thomsen; Leen Rigouts; Erik Michael Rasmussen; Didi Bang; Gertjan Bernaerts; Jim Werngren; Juan Carlos Toro; Sven Hoffner; Doris Hillemann; Erik Svensson
Journal:  J Clin Microbiol       Date:  2013-09-25       Impact factor: 5.948

10.  Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China.

Authors:  Yu Pang; Yang Zhou; Bing Zhao; Guan Liu; Guanglu Jiang; Hui Xia; Yuanyuan Song; Yuanyuan Shang; Shengfen Wang; Yan-lin Zhao
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

View more
  4 in total

Review 1.  Mechanisms and clinical relevance of bacterial heteroresistance.

Authors:  Dan I Andersson; Hervé Nicoloff; Karin Hjort
Journal:  Nat Rev Microbiol       Date:  2019-06-24       Impact factor: 60.633

2.  Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing.

Authors:  Willy Ssengooba; Germine Nakayita; Carolyn C Namaganda; Moses L Joloba
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

3.  Rapid Diagnosis Of Multidrug-Resistant Tuberculosis Impacts Expenditures Prior To Appropriate Treatment: A Performance And Diagnostic Cost Analysis.

Authors:  Xuezheng Li; Yunfeng Deng; Junling Wang; Hui Jing; Wei Shu; Jingmin Qin; Yu Pang; Xin Ma
Journal:  Infect Drug Resist       Date:  2019-11-14       Impact factor: 4.003

4.  Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China.

Authors:  Yu Pang; Haiyan Dong; Yaoju Tan; Yunfeng Deng; Xingshan Cai; Hui Jing; Hui Xia; Qiang Li; Xichao Ou; Biyi Su; Xuezheng Li; Zhiying Zhang; Junchen Li; Jiankang Zhang; Shitong Huan; Yanlin Zhao
Journal:  Sci Rep       Date:  2016-05-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.